Press release
Aneurysmal Subarachnoid Hemorrhage Market Growth to Accelerate in Forecast Period (2024-2034), DelveInsight Analyzes | Acasti Pharma, BIT Pharma, Aaron Cook, Haaglanden Medical Centre
To Know in detail about the Aneurysmal Subarachnoid Hemorrhage market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Aneurysmal Subarachnoid Hemorrhage Market Forecast
https://www.delveinsight.com/sample-request/aneurysmal-subarachnoid-hemorrhage-sah-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Some of the key facts of the Aneurysmal Subarachnoid Hemorrhage Market Report:
• The Aneurysmal Subarachnoid Hemorrhage market size is anticipated to grow with a significant CAGR during the study period (2020-2034)
• In February 2025, Grace Therapeutics, Inc. (Nasdaq: GRCE), formerly Acasti Pharma Inc., a late-stage biopharmaceutical company developing GTx-104-an innovative injectable formulation of nimodipine for IV infusion to address unmet medical needs in aneurysmal subarachnoid hemorrhage (aSAH) patients-announced that its Phase 3 STRIVE-ON safety trial (NCT05995405) achieved its primary endpoint, demonstrating clinical benefits over orally administered nimodipine.
• In 2023, the United States accounted for the second-largest share of incident cases of aSAH among the 7 major markets, comprising approximately 24.5% of the total share.
• According to DelveInsight's analysis, the total number of incident cases of Aneurysmal Subarachnoid Hemorrhage (aSAH) in the 7 major markets (7MM) was approximately 54,600 cases in 2023.
• In 2023, Japan recorded the highest incident population of Aneurysmal Subarachnoid Hemorrhage (aSAH), with approximately 32,000 cases.
• According to a study by Ziu et al. (2023), the annual incidence of subarachnoid hemorrhage in the United States ranges from 10 to 14 cases per 100,000 individuals.
• Key Aneurysmal Subarachnoid Hemorrhage Companies: Acasti Pharma Inc., BIT Pharma, Aaron Cook, Haaglanden Medical Centre, and others
• Key Aneurysmal Subarachnoid Hemorrhage Therapies: GTX-104, NicaPlant (nicardipine), Telavancin Injection, C1 Esterase Inhibitor Injection, and others
• Subarachnoid hemorrhage (aSAH) is more prevalent in females, constituting approximately 66% of the total incident cases of aSAH.
• The Aneurysmal Subarachnoid Hemorrhage market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Aneurysmal Subarachnoid Hemorrhage pipeline products will significantly revolutionize the Aneurysmal Subarachnoid Hemorrhage market dynamics.
Aneurysmal Subarachnoid Hemorrhage Overview
Aneurysmal Subarachnoid Hemorrhage (aSAH) is a type of stroke caused by bleeding into the space surrounding the brain, known as the subarachnoid space, due to the rupture of a brain aneurysm. This condition is characterized by sudden and severe headaches, often described as the worst headache of a person's life, along with other symptoms such as nausea, vomiting, stiff neck, sensitivity to light, and loss of consciousness.
Get a Free sample for the Aneurysmal Subarachnoid Hemorrhage Market Forecast, Size & Share Analysis Report:
https://www.delveinsight.com/report-store/aneurysmal-subarachnoid-hemorrhage-sah-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Aneurysmal Subarachnoid Hemorrhage Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2020 to 2034. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.
Aneurysmal Subarachnoid Hemorrhage Epidemiology Segmentation:
The Aneurysmal Subarachnoid Hemorrhage market report proffers epidemiological analysis for the study period 2020-2034 in the 7MM segmented into:
• Total Prevalence of Aneurysmal Subarachnoid Hemorrhage
• Prevalent Cases of Aneurysmal Subarachnoid Hemorrhage by severity
• Gender-specific Prevalence of Aneurysmal Subarachnoid Hemorrhage
• Diagnosed Cases of Episodic and Chronic Aneurysmal Subarachnoid Hemorrhage
Download the report to understand which factors are driving Aneurysmal Subarachnoid Hemorrhage epidemiology trends @ Aneurysmal Subarachnoid Hemorrhage Epidemiology Forecast
https://www.delveinsight.com/sample-request/aneurysmal-subarachnoid-hemorrhage-sah-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Aneurysmal Subarachnoid Hemorrhage Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Aneurysmal Subarachnoid Hemorrhage market or expected to get launched during the study period. The analysis covers Aneurysmal Subarachnoid Hemorrhage market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Aneurysmal Subarachnoid Hemorrhage Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.
Aneurysmal Subarachnoid Hemorrhage Therapies and Key Companies
• GTX-104: Acasti Pharma Inc.
• NicaPlant (nicardipine) : BIT Pharma
• Telavancin Injection: Aaron Cook
• C1 Esterase Inhibitor Injection: Haaglanden Medical Centre
Discover more about therapies set to grab major Aneurysmal Subarachnoid Hemorrhage market share @ Aneurysmal Subarachnoid Hemorrhage Treatment Landscape
https://www.delveinsight.com/sample-request/aneurysmal-subarachnoid-hemorrhage-sah-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Aneurysmal Subarachnoid Hemorrhage Market Strengths
• Several trials are underway that may offer results that will further enhance the practice of the anesthesiologist and thus improve the short-term and long-term outcomes for aSAH
• The 20th century has seen a great advancement in diagnosis, starting with ability to recognize the condition at all during life.
Aneurysmal Subarachnoid Hemorrhage Market Opportunities
• Limited therapies are available for treatment aSAH; thus providing profitable opportunities for emerging therapies.
• Demands of advanced therapeutics and the presence of a significant number of pipeline drugs.
• High R&D investment and marketing outlay for innovative drugs.
Scope of the Aneurysmal Subarachnoid Hemorrhage Market Report
• Study Period: 2020-2034
• Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
• Key Aneurysmal Subarachnoid Hemorrhage Companies: Acasti Pharma Inc., BIT Pharma, Aaron Cook, Haaglanden Medical Centre, and others
• Key Aneurysmal Subarachnoid Hemorrhage Therapies: GTX-104, NicaPlant (nicardipine), Telavancin Injection, C1 Esterase Inhibitor Injection, and others
• Aneurysmal Subarachnoid Hemorrhage Therapeutic Assessment: Aneurysmal Subarachnoid Hemorrhage current marketed and Aneurysmal Subarachnoid Hemorrhage emerging therapies
• Aneurysmal Subarachnoid Hemorrhage Market Dynamics: Aneurysmal Subarachnoid Hemorrhage market drivers and Aneurysmal Subarachnoid Hemorrhage market barriers
• Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
• Aneurysmal Subarachnoid Hemorrhage Unmet Needs, KOL's views, Analyst's views, Aneurysmal Subarachnoid Hemorrhage Market Access and Reimbursement
To know more about Aneurysmal Subarachnoid Hemorrhage companies working in the treatment market, visit @ Aneurysmal Subarachnoid Hemorrhage Clinical Trials and Therapeutic Assessment
https://www.delveinsight.com/sample-request/aneurysmal-subarachnoid-hemorrhage-sah-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Table of Contents
1. Aneurysmal Subarachnoid Hemorrhage Market Report Introduction
2. Executive Summary for Aneurysmal Subarachnoid Hemorrhage
3. SWOT analysis of Aneurysmal Subarachnoid Hemorrhage
4. Aneurysmal Subarachnoid Hemorrhage Patient Share (%) Overview at a Glance
5. Aneurysmal Subarachnoid Hemorrhage Market Overview at a Glance
6. Aneurysmal Subarachnoid Hemorrhage Disease Background and Overview
7. Aneurysmal Subarachnoid Hemorrhage Epidemiology and Patient Population
8. Country-Specific Patient Population of Aneurysmal Subarachnoid Hemorrhage
9. Aneurysmal Subarachnoid Hemorrhage Current Treatment and Medical Practices
10. Aneurysmal Subarachnoid Hemorrhage Unmet Needs
11. Aneurysmal Subarachnoid Hemorrhage Emerging Therapies
12. Aneurysmal Subarachnoid Hemorrhage Market Outlook
13. Country-Wise Aneurysmal Subarachnoid Hemorrhage Market Analysis (2020-2034)
14. Aneurysmal Subarachnoid Hemorrhage Market Access and Reimbursement of Therapies
15. Aneurysmal Subarachnoid Hemorrhage Market Drivers
16. Aneurysmal Subarachnoid Hemorrhage Market Barriers
17. Aneurysmal Subarachnoid Hemorrhage Appendix
18. Aneurysmal Subarachnoid Hemorrhage Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
Related Reports:
Aneurysmal Subarachnoid Hemorrhage Pipeline https://www.delveinsight.com/report-store/aneurysmal-subarachnoid-hemorrhage-sah-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
"Aneurysmal Subarachnoid Hemorrhage Pipeline Insight, 2025" report by DelveInsight outlines comprehensive insights of present clinical development scenarios and growth prospects across the Aneurysmal Subarachnoid Hemorrhage market. A detailed picture of the Aneurysmal Subarachnoid Hemorrhage pipeline landscape is provided, which includes the disease overview and Aneurysmal Subarachnoid Hemorrhage treatment guidelines.
Aneurysmal Subarachnoid Hemorrhage Epidemiology https://www.delveinsight.com/report-store/aneurysmal-subarachnoid-hemorrhage-sah-epidemiology-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Aneurysmal Subarachnoid Hemorrhage Epidemiology Forecast to 2034' report delivers an in-depth understanding of the disease, historical and forecasted Aneurysmal Subarachnoid Hemorrhage epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Latest Reports by DelveInsight
• Sglt2 Inhibitors Market: https://www.delveinsight.com/report-store/sglt2-inhibitors-market
• Electroencephelographs Pipeline Insight: https://www.delveinsight.com/report-store/epilepsy-pipeline-insight
• Fabry Disease Market: https://www.delveinsight.com/report-store/fabry-disease-market
• Dental Implants And Prosthesis Market: https://www.delveinsight.com/report-store/dental-implants-and-prosthesis-market
• Peritoneal Dialysis Equipment Market: https://www.delveinsight.com/report-store/peritoneal-dialysis-equipment-market
• Drug-eluting Stents Market Market: https://www.delveinsight.com/report-store/drug-eluting-stents-market
• Sinusitis Market: https://www.delveinsight.com/report-store/chronic-rhinosinusitis-with-nasal-polyps-market
• Pd-1 & Pdl1 Market: https://www.delveinsight.com/report-store/pd-1-and-pd-l1-inhibitors-competitive-landscape
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email: info@delveinsight.com
Contact No.: +14699457679
City: 304 S. Jones Blvd #2432, Las Vegas
State: Nevada (89107)
Country: United States
Website: https://www.delveinsight.com/consulting
About DelveInsight
DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Aneurysmal Subarachnoid Hemorrhage Market Growth to Accelerate in Forecast Period (2024-2034), DelveInsight Analyzes | Acasti Pharma, BIT Pharma, Aaron Cook, Haaglanden Medical Centre here
News-ID: 4132308 • Views: …
More Releases from DelveInsight Business Research
Global Tumor Ablation Market to reach USD 4,595.68 million by 2032 at a CAGR of …
According to DelveInsight's analysis, The global Tumor Ablations (EHR) market is experiencing significant growth, driven by the increasing prevalence of chronic diseases that require continuous monitoring, data management, and coordinated long-term care. This demand has fueled the need for integrated healthcare systems capable of connecting patient information across multiple departments and care settings. To support this trend, governments worldwide are introducing initiatives, funding, mandates, and regulatory frameworks to promote EHR…
Global Spinal Implants Market to reach USD 21,899.24 million by 2032 at a CAGR o …
According to DelveInsight's analysis, The increasing prevalence of spinal disorders, especially among the aging population, has substantially driven the demand for corrective surgical procedures. At the same time, the rise in sports-related and trauma-induced spinal injuries is boosting the need for advanced implantable solutions. Additionally, there is a growing preference for non-fusion and motion-preserving devices that maintain spinal mobility and improve patient outcomes, particularly among younger and more active individuals.…
Global Vascular Stents Market to reach USD 18,277.68 million by 2032 at a CAGR o …
According to DelveInsight's analysis, The increasing global incidence of cancer is boosting the demand for effective treatment options such as tumor ablation. Minimally invasive procedures are becoming more popular due to their shorter recovery periods, reduced risks, and cost-effectiveness compared to conventional surgery. At the same time, technological advancements in tumor ablation devices-such as improvements in radiofrequency, microwave, and cryoablation technologies-have enhanced precision, safety, and effectiveness, making these procedures increasingly…
Global Vascular Grafts Market to reach USD 3,153.39 million by 2032 at a CAGR of …
According to DelveInsight's analysis, The increasing prevalence of cardiovascular disorders, along with risk factors like hypertension, diabetes, and obesity, is fueling the demand for surgical interventions, thereby supporting the growth of the vascular graft market. Moreover, greater awareness and the expansion of cardiovascular screening programs are enabling earlier diagnosis and timely treatment, further driving the need for vascular grafts.
DelveInsight's "Vascular Grafts Market Insights, Competitive Landscape and Market Forecast-2032" report provides…
More Releases for Subarachnoid
Subarachnoid Hemorrhage Market Detailed Industry Report Analysis 2025-2034
Introduction
Subarachnoid hemorrhage (SAH) is a severe neurological condition that occurs when bleeding takes place in the space between the brain and the thin tissues covering it. Although it represents a smaller fraction of stroke cases compared to ischemic strokes, it is associated with disproportionately higher morbidity and mortality rates. With lifestyle changes, rising incidence of brain aneurysms, and growing awareness of neurological health, the global demand for effective diagnostics, surgical…
Aneurysmal Subarachnoid Hemorrhage (aSAH) Market Outlook 2025-2034
Introduction
Aneurysmal Subarachnoid Hemorrhage (aSAH) is a life-threatening neurological emergency caused by the rupture of an intracranial aneurysm, leading to bleeding in the subarachnoid space. It accounts for a significant proportion of hemorrhagic strokes and carries high rates of mortality and long-term disability. Prompt diagnosis and treatment are critical for patient survival, driving demand for advanced imaging, neurosurgical devices, and neurocritical care.
Growing incidence of hypertension, smoking, alcohol use, and age-related vascular…
Aneurysmal Subarachnoid Hemorrhage Drugs Market to Witness Robust Expansion by 2 …
Aneurysmal subarachnoid hemorrhage drugs market is anticipated to grow at a significant CAGR during the forecast period. Aneurysmal subarachnoid hemorrhage (aSAH) is a life-threatening type of stroke. It is caused by bleeding in the space surrounding the brain. It mostly occurs due to bursts and leaks of a weak area in a blood vessel on the surface of the brain due to which blood builds up around the brain and…
Aneurysmal Subarachnoid Hemorrhage Drugs Market Size & Growth Analysis Report, 2 …
The global aneurysmal subarachnoid hemorrhage drugs market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Aneurysmal subarachnoid hemorrhage (aSAH) is a life-threatening type of stroke. It is caused by bleeding in the space surrounding the brain. It mostly occurs due to bursts and leaks of a weak area in a blood vessel on the surface of the brain due to which blood builds up around…
Aneurysmal Subarachnoid Hemorrhage Market Share Analysis Report of Key Industry …
Accurate market intelligence can be obtained with the help of SWOT analysis provided in the first class Aneurysmal Subarachnoid Hemorrhage market report that aid businesses identify opportunities as well as both internal and external influences. With the wonderful secondary research expertise and the ability to find correct information sources, such as local government websites and publications, the report has been produced. The customized research process is designed to put together…
Aneurysmal Subarachnoid Hemorrhage Market (2019-2026) Analysis of Top industry S …
According to a new report published by Allied Market Research, titled, "Aneurysmal Subarachnoid Hemorrhage Market by Therapy Type (Computed Tomography (CT) Scan, Magnetic Resonance Imaging (MRI), Lumbar Puncture, Xanthochromia, Cerebral Angiography, and Transcranial Doppler Ultrasound) and End User (Hospitals, Clinics, and Other) - Global Opportunity Analysis and Industry Forecast, 2020-2027".
The global market size of Aneurysmal Subarachnoid Hemorrhage market is $XX million in 2019 with XX CAGR, and it is expected…
